Back to catalog
50 mg
Research grade
Metabolic
In Stock
Tirzepatide
Compound studied for type 2 diabetes and widely researched for weight regulation via dual GLP-1 and GIP receptor activity.
$168.00
per vial (50 mg)
1
For research use only
This product is intended for qualified laboratory research and is not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Researched benefits
- Significant weight loss (one of the strongest effects among current compounds)
- Appetite suppression / reduced cravings
- Improved blood sugar control (A1C reduction)
- May improve insulin resistance and metabolic health
- Some improvements in blood pressure and cholesterol
Available sizes
50 mg — $201.6
30 mg — $108
How it works
- GLP-1 receptor → reduces appetite, slows digestion, improves insulin control
- GIP receptor → improves insulin response and may further support fat loss
Related research peptides
Retatrutide · 30 mg
In Stock
Metabolic
Retatrutide
Triple agonist (GLP-1, GIP, glucagon) studied for strong weight regulation effects.
30 mgResearch grade
$168.00
MOTS-c · 40 mg
In Stock
Metabolic
MOTS-c
Mitochondrial-derived peptide involved in metabolism, energy use, and insulin sensitivity.
40 mgResearch grade
$180.00
AOD-9604 · 5 mg
In Stock
Metabolic
AOD-9604
Synthetic HGH fragment designed to target fat metabolism without other GH effects.
5 mgResearch grade
$72.00